Flamel Technologies

Since the acquisition of Éclat, we have implemented a balanced business model allowing Flamel to commercialize niche branded (Bloxiverz®® and Vazculep®) and generic pharmaceutical products in the U.S. and other countries as appropriate, and blend novel, high-value internally developed products with our drug delivery and capabilities. Flamel’s new model allows us now to select, develop, seek approval for, and commercialize niche branded products mainly in the U.S. and most of the opportunities are self-funded. By adopting this revised strategy, the Company makes itself less dependent on the often changing strategies of partners in the future. Nevertheless, Flamel is still exploring development, supply and licensing opportunities for either its drug delivery platforms or its proprietary products with carefully selected third parties, but, unlike our historical operations, will not be dependent completely on those partnerships to create revenue and profit opportunities.
Type
Public
HQ
Vénissieux, FR
Founded
1990
Size (employees)
109 (est)
Website
flamel.com
Flamel Technologies was founded in 1990 and is headquartered in Vénissieux, FR

Flamel Technologies Office Locations

Flamel Technologies has an office in Vénissieux

Flamel Technologies Data and Metrics

Flamel Technologies Financial Metrics

USD

Net income (FY, 2016)

(41.3 b)

EBIT (FY, 2016)

(5 b)

Market capitalization (18-Nov-2016)

432.2 m

Closing share price (18-Nov-2016)

10.8

Cash (31-Dec-2016)

39.2 m

EV

393.8 m
Flamel Technologies's current market capitalization is $432.2 m.
USDFY, 2015FY, 2016

R&D expense

25.6 m34.6 b

General and administrative expense

21.7 m44.2 b

Operating expense total

47.3 m78.8 b

EBIT

71.4 m(5 b)

Interest expense

(1.4 m)(963 m)

Pre tax profit

78.4 m(9.7 b)

Income tax expense

37.7 m31.6 b

Net Income

40.7 m(41.3 b)
USDQ1, 2016Q2, 2016

R&D expense

5.4 m7.6 m

General and administrative expense

9.5 m11.3 m

Operating expense total

14.8 m18.9 m

EBIT

5.5 m(11.5 m)

Interest expense

(175 k)(263 k)

Pre tax profit

765 k(12.5 m)

Income tax expense

7.1 m7.4 m

Net Income

(6.4 m)(20 m)
USDFY, 2015FY, 2016

Cash

65.1 m39.2 m

Accounts Receivable

17.8 m

Inventories

3.3 m

Current Assets

166.3 m181.2 m

PP&E

2.6 m3.3 m

Goodwill

18.5 m18.5 m

Total Assets

215 m245.5 m

Accounts Payable

612 k7.1 m

Total Debt

815 k

Current Liabilities

48.8 m62.4 m

Total Liabilities

203.4 m

Additional Paid-in Capital

364 m385 m

Retained Earnings

(279.8 m)(319.8 m)

Total Equity

67.9 m42.1 m

Debt to Equity Ratio

0 x

Debt to Assets Ratio

0 x

Financial Leverage

3.2 x5.8 x
USDQ1, 2016Q2, 2016

Cash

37.9 m23.9 m

Accounts Receivable

4.9 m9.5 m

Inventories

5.3 m3.6 m

Current Assets

180.5 m177.6 m

PP&E

3.1 m3.1 m

Goodwill

24.1 m18.7 m

Total Assets

255 m249.7 m

Accounts Payable

17.7 m7 m

Current Liabilities

60.9 m58.2 m

Additional Paid-in Capital

366.5 m368.9 m

Retained Earnings

(286.2 m)(304.5 m)

Total Equity

69.7 m51.8 m

Financial Leverage

3.7 x4.8 x
USDFY, 2015FY, 2016

Net Income

40.7 m(41.3 m)

Depreciation and Amortization

13.1 m14.5 m

Accounts Receivable

(10.1 m)

Inventories

1.8 m

Cash From Operating Activities

84.3 m18.9 m

Purchases of PP&E

(1.6 m)(1.2 m)

Cash From Investing Activities

(31.7 m)(36.6 m)

Cash From Financing Activities

(23.8 m)(8 m)

Interest Paid

4.7 m788 k
USDQ1, 2016Q2, 2016

Net Income

(6.4 m)(20 m)

Depreciation and Amortization

3.8 m

Accounts Receivable

2.1 m9.5 m

Inventories

1.2 m3.6 m

Accounts Payable

7 m

Cash From Operating Activities

22.5 m

Purchases of PP&E

(460 k)

Cash From Investing Activities

(41 m)

Cash From Financing Activities

(9.1 m)

Income Taxes Paid

6.3 m
Y, 2016

EV/EBIT

-0.1 x

EV/CFO

20.8 x

Financial Leverage

5.8 x

Traffic Overview of Flamel Technologies

Flamel Technologies Company Life and Culture

You may also be interested in